|
HDCN News Archive -- Peritoneal Dialysis |
|---|
|
|
|---|
| M16 |
MIT research team crafts films resistant to bacterial adhesion. |
| F29 |
2008 Annual Dialysis Conference begins tomorrow. Abstracts available at this link. |
| J02 |
FDA clears quick molecular-biology-based blood test for MRSA. |
| D19 |
Advances in PD 2007. Full text online. |
| O10 |
RIP2 biomarker identifies peritonitis patients requiring more intensive treatment. |
| A07 |
Publix supermarkets to offer up to 14-days of free antibiotics. |
| J09 |
FDA warning: precipitation when infusing ceftriaxone with calcium-containing solutions. |
| J09 |
Slime busting bacteriophage virus could clean up biofilm. |
| M26 |
Baxter focusing on growing PD market, especially in developing countries. |
| M02 |
NEJM: Vancomycin-induced thrombocytopenia: the article link |
| F28 |
NEJM: Immune-mediated thrombocytopenia linked to vancomycin use. |
| F21 |
Alagebrium, a drug that targets AGEs (advanced glycosylation end-products) given IP has beneficial effects on peritoneal permeability (animal study). |
| J29 |
Bacteriophages and antibiotics exhibit synergistic effect; may lower needed dose by a factor of 50. |
| J22 |
Home microwave ovens useful for sterilization of sponges and towelettes. |
| D29 |
Spiky surface coating kills bacteria. |
| N26 |
HDCN: Search index updated for audiofiles, slide/audio talks, articles, and abstracts |
| N16 |
Resveratrol makes champion athletes out of fat mice eating a high-fat diet. |
| S11 |
Bacterial conversation stoppers may block formation of biofilm |
| S11 |
Chitosan (from crabs and shrimp) found to block formation of biofilm. |
| A30 |
Carbs linked to obesity in a mouse model |
| A16 |
Antibiotic skin infections becoming commonplace |
| A09 |
Peritoneal dialysis using perfluorocarbons to help oxygenate the blood (animal model) |
| A09 |
Chronically high blood sugar linked to risk of cognitive impairment |
| J16 |
CARI (Australasian) Clinical Practice Guidelines published (53 free full text review papers!) |
| J14 |
Low carb diet improves glycemic control in diabetes (pdf) |
| J14 |
Low carb diet reverses progressive renal disease in diabetic (case report) |
| J01 |
For PD patients with diabetes: It's the carbs, stu... |
| M15 |
Aspirin may protect against gentamicin-induced hearing loss. |
| M06 |
Annals: Dramatic recent rise in community-acquired MRSA infections. |
| J25 |
32% of Americans carry S. aureus in their noses, and 1% (2 million) carry MRSA. |
| J09 |
AAKP releases new patient brochure: Understanding your Peritoneal Dialysis Options |
| J05 |
MRSA patterns in ICUs changing: 64% prevalence rate, hardier, bugs, but less multi-drug resistance. |
| D21 |
New study says that two million Americans are nasal carriers of MRSA. |
| D17 |
Heteropolymer antibodies - a new approach to treat and prevent? MRSA infections. |
| D17 |
CDC recommends new blood test to diagnose TB infection. |
| D05 |
Dialysis patient adventurer gets severe peritonitis on sailboat voyage. |
| N23 |
Baxter to set up home dialysis care centers in India. |
| N01 |
Nabi StaphVax vaccine fails in clinical trial ; development cancelled. |
| O26 |
ASN Renal Week 2005 abstracts now available on-line. |
| S13 |
High blood sugar levels linked to heart disease, even in nondiabetics. |
| S06 |
Number of dialysis patients in Scotland rises by 50%. |
| A02 |
CHOICE study reports in Annals that PD mortality higher than Hemo. |
| J22 |
Nabi initiates phase 1 trial of vaccine against another strain of S. aureus. |
| M18 |
Hemodialysis options brochure now available in Spanish via AAKP website. |
| A27 |
ISPD North American chapter meeting this weekend in Chicago. |
| A18 |
Kaiser and Wellbound partner to offer home HD and PD. |
| A12 |
Fresenius to get 510k approval for PD Liberty cycler. |
| A12 |
Sarah Prichard named Baxter VP of Global Affairs |
| M22 |
Baxter alert: Falsely high glucose readings when icodextrin PD fluid is used. |
| M02 |
Gambro to switch to low GDP biocompatible dialysate for PD. |
| D16 |
ANNA: Peritoneal Dialysis "travel toolbox" (.pdf) |
| D15 |
Fujisawa and Fresenius to link up to provide PD in Japan. |
| D09 |
Slowly growing nests of bacteria may be key to infection relapse. |
| D04 |
Gene identified that makes biofilm bacteria hibernate and evade antibiotics. |
| O13 |
Nabi gets FDA fast-track approval for its Staph vaccine |
| A17 |
Nabi completes patient enrollment for Phase III trial of StaphVax |
| J20 |
Lysophosphatidic acid may potentiate efficacy of antibiotics |
| J18 |
ASM conference on the New Phage Biology, August 1-5, Key Biscayne, FL |
| J13 |
Nabi ramping up manufacturing capacity of its Staph vaccine |
| J21 |
Vancomycin susceptibility in MRSA lineages (Emerging Infect Dis paper) |
| J21 |
MRSA (superbug) death rates set to double as vanco resistance grows |
| F11 |
JAMA: Patients more satisfied with PD than with HD in the first few months |
| D10 |
Company in India unveils low-cost CAPD system |
| N13 |
Peritoneal dialysis nurse resource guide from ANNA (PDF) |
| O31 |
Amino acid PD solution impairs forearm vasodilatation |
| O29 |
Blindness in children on PD reported; believed due to ischemic optic neuropathy |
| O29 |
Quebec company developing rapid, 1 hour screening test for MR Staph aureus |
| O19 |
Computer crime in the health care field: 2003 survey results |
| S12 |
FDA approves daptomycin, first in a new class of antibiotics |
| A22 |
CDC: VISA/VRSA (vancomycin- resistant Staph) testing algorithm |
| J16 |
Annals paper suggests that ramipril may help maintain GFR in PD patients |
| J05 |
Amiodarone appears to have strong fungicidal ability |
| M17 |
Work on Staph vaccine by Nabi pharmaceuticals progressing |
| A29 |
Brigham: Immune-boosting properties of tea help fight infections |
| M24 |
Baxter to buy company plant that makes icodextrin |
| M05 |
Abstracts from 23rd Annual Dialysis Conference in Seattle |
| F27 |
Surface slime from rock pools may kill MRSA bacteria |
| F21 |
MSH-like peptide destroys almost all Candida albicans subtypes |
| F07 |
Insect antibiotics: Resistance is futile! |
| F06 |
MMWR: Methicillin-resistant Staph aureus skin infections |
| J17 |
HDCN: PD channel talk list updated |
| D31 |
ADC 2002 meeting papers in PDF format (vol 18, 2002) |
| D23 |
FDA approves U.S. sale of icodextrin solution |
| D13 |
MRSA deaths on the rise |
| D11 |
New antibiotic AP158 (Antex) active against mupirocin-resistant Staph. aureus |
| O15 |
FDA debates restrictions on antibiotic use in animals |
| O09 |
Endogenous antimicrobial peptides play an important role in the skin |
| J29 |
38-year old APD patient to climb Mont Blanc, perform a PD exchange at its summit |
| J12 |
Vancomycin resistance genes identified in enterococci |
| M30 |
Lactoferrin in tears, mucus, helps prevent biofilm formation |
| M17 |
Vancomycin AND methicillin-resistant Staph aureus in an English patient |
| M15 |
VA study shows mupirocin works, but resistant Staph is a problem |
| M14 |
Antistaphylococcal monoclonal antibodies show encouraging results |
| M05 |
Blagg and Lockridge issue appeal to prevent funding reduction for home dialysis |
| M02 |
Ramoplanin suppresses VRE in GI tract of colonized patients |
| A18 |
ADEMEX study results on PD adequacy published in May JASN |
| A14 |
Can bacteria warn their brethren to beware of antibiotic attack? |
| M06 |
AGE crosslink-breaking drug reduced peritoneal angiogenesis |
| M04 |
Dermcidin - source article - is excessive skin cleansing bad for exit sites? |
| M04 |
Novel antibiotic found in human sweat (free Lancet reg required) |
| F11 |
Mupirocin-resistant Staph. aureus emerge in PD patients |
| D11 |
FDA approves Baxter pediatric home APD system |
| D08 |
Bacteriophages kill Streptococci effectively and selectively |
| N07 |
Alteon announces study of AGE-crosslink breaker in PD patients |
| S23 |
CANUSA dose effect may have been confounded by residual renal function |
| A24 |
Texas Department of Health to stop paying for Renagel |
| J30 |
ISPD: Residual renal function in kids associated with growth |
| J28 |
ISPD: PD increases lipoprotein a - Lp(a) |
| J28 |
Randomized PD study challenges need for high PD
prescriptions |
| Jul |
Linezolid resistance in peritonitis-associated S. aureus |
| Jul |
Volume expansion and LVH in CAPD patients |
| Jul |
Polyglucose overnight changes PETT results |
| Jun |
Review of Pseudomonas peritonitis |
| May |
Upregulation of aquaporin-1 by human mesothelial cells in vitro |
| May |
Peritoneal glucose exposure and changes in membrane solute transport |
| Mar |
Diuretics and preservation of residual renal function |
| Mar |
Strict volume control normalizes hypertension in PD |
| Feb |
High peritoneal transport status and morbidity |
| Jan |
Nasal carriage as a source of S. aureus bacteremia |
| Jan |
Same Staph at exit site, nose, and hands in peritonitis |
| 2000 |
Sodium removal during CAPD: Sodium electrode error |
| 2000 |
Tidal PD vs. APD comparison |
| 2000 |
Allergic reactions to icodextrin |
| 2000 |
High creatinine excretion ratio predicts a good outcome |
| 2000 |
PD adequacy and risk of death |
| 2000 |
The effect of HD during break-in on Kru |
| 1999 |
Tolerance of large exchange volumes in PD |
| 1999 |
Value of scintigraphy in chronic PD |